Neuren Pharmaceuticals Limited (ASX:NEU)
Australia flag Australia · Delayed Price · Currency is AUD
13.91
0.00 (0.04%)
Last updated: Jun 5, 2025

Neuren Pharmaceuticals Market Cap

Neuren Pharmaceuticals has a market cap or net worth of 1.74 billion as of June 5, 2025. Its market cap has decreased by -34.38% in one year.

Market Cap
1.74B
Enterprise Value
1.51B
Revenue
216.83M
Ranking
n/a
PE Ratio
12.80
Stock Price
13.91

Market Cap Chart

Since February 3, 2005, Neuren Pharmaceuticals's market cap has increased from 20.93M to 1.74B, an increase of 8,200.69%. That is a compound annual growth rate of 24.26%.

History

DateMarket Cap% Change
Jun 5, 20251.74B9.41%
Dec 31, 20241.59B-50.04%
Dec 29, 20233.18B217.33%
Dec 30, 20221.00B110.88%
Dec 31, 2021474.89M222.46%
Dec 31, 2020147.27M-40.72%
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro
Dec 31, 2015 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
CSL Limited 118.85B
Pro Medicus 29.52B
Cochlear 17.55B
Sonic Healthcare 12.74B
Telix Pharmaceuticals 8.81B
Ramsay Health Care 8.69B
Ansell 4.54B
Regis Healthcare 2.40B
Market Cap Rankings